世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

経肺薬剤デリバリーシステム:技術と世界市場

Pulmonary Drug Delivery Systems: Technologies and Global Markets

 

出版社 出版年月電子版価格 ページ数
BCC Research
BCCリサーチ
2018年4月US$5,500
シングルユーザライセンス
121

サマリー

この調査レポートは経肺薬剤デリバリーシステムの技術と世界市場を分析・予測したBCC Researchの市場調査報告書です。

Description

Report Scope:

This report will provide a detailed look at the pulmonary drug delivery systems market, highlighting major pulmonary diseases with detailed epidemiology for major disease areas such as asthma, COPD and cystic fibrosis. The report includes an industry-wide assessment of the novel products, launches, recent approvals, research and development pipeline, and blockbuster drugs.

In the report the regulatory scenario of pulmonary drug delivery systems is discussed for device type. This will include products approved by regulatory authorities in recent years. Products under development or in different stages of clinical trials are analyzed in the Pipeline Analysis section.

A discussion of the major players is included in the Competitive Landscape section. The Competitive Landscape section provides trends in product launch, collaborations, mergers and acquisitions, and other agreements. Company profiles of major players operating in the pulmonary drug delivery systems market are included with an overview, key product offerings, financials, strategies, strength, weakness, opportunities and threats (SWOT) and developments. The report will be useful for analysis of the leading products and will enable readers to recognize growing brands, key device types and leading manufacturing companies with significant market share.

Report Includes:

- 74 tables
- A detailed overview and analysis of the global markets for pulmonary drug delivery systems
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Assessments of pulmonary drug delivery systems by regions, delivery systems/types, and disease areas
- A look at the regulatory environment, which has been a driving force in the healthcare industry
- Reviews of key developments, novel product innovations, and recent strategic industry activities of major players across various product categories
- Detailed profiles of major vendors in the market, including 3M Pharmaceuticals Inc., AstraZeneca plc, Cipla Inc., GlaxoSmithKline plc and Lupin Ltd



目次

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Dynamics and Technology Background
Market Definition and Overview
Mechanism of Action
Advantages
Limitations/Challenges
Pulmonary Conditions and Therapies
Introduction to the Respiratory System
Market Driving Factors and Trends
Improved Patient Compliance and Ease of Use Leading to Adoption of Inhalation Products
Cost Pressure on Countries Imposing Adoption of Cost-Effective Devices
Rising Incidence of Asthma and COPD in Developing and Developed Regions
Market Restraints
Competition from Generics on the Rise Due to Patent Expiry of Blockbuster Products
Market Opportunities
Introduction of Smart Nebulizers
Regulation and Legislation
United States
Chapter 4 Market Breakdown by Pulmonary Drug Delivery Systems
Overview of Inhalation Techniques
Leading Respiratory Products
Dry Powder Inhalers (DPIs)
Overview
Marketed Products
Market Size and Forecast
Metered Dose Inhalers (MDI's)
Overview
Marketed Products
Market Size and Forecast
Nebulizers
Overview
Marketed Products Overview by Manufacturer)
Market Size and Forecast
Chapter 5 Pulmonary Drug Delivery Drugs in Use
Therapeutic Agents Administered via Inhalation
Steroids
Bronchodilators
Chapter 6 Market Breakdown by Disease Area
Introduction
Asthma
Asthma Attack
Asthma and Obesity
Mortality
Disease Classification
Diagnosis
Treatment and Therapies
Market Size and Forecasts
Chronic Obstructive Pulmonary Disease (COPD)
Diagnosis
Treatment and Therapies
Market Size and Forecasts
Other Diseases
Market Size and Forecast
Chapter 7 Market Breakdown by Region
North America
U.S.A.
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Rest of Asia Pacific
Middle East and Africa
South America
Chapter 8 Competitive Landscape and Key Developments
Leading Players and Market Structure Analysis
Patent Analysis
List of Key Patents
Pipeline Analysis
Fasenra (benralizumab) Approved for Severe Eosinophilic Asthma in U.S., Japan and European Countries
GOLDEN Clinical Study Analysis of SUN-101/ eFlow (Glycopyrrolate) For the Treatment of COPD
Key Developments
Mergers and Acquisitions
Development of Innovative Products/Novel Product Launches
Agreements, Collaborations and Partnerships
Chapter 9 Company Profiles
3M PHARMACEUTICALS, INC.
Company Overview
Product Information
Development and Strategies
Financials
ASTRAZENECA PLC
Company Overview
Development and Strategies
Financials
BOEHRINGER INGELHEIM GMBH
Company Overview
Product Information
Development and Strategies
Financials
CIPLA, INC.
Company Overview
Product Information
Development and Strategies
Financials
DR. REDDY'S LABORATORIES LTD.
Company Overview
Product Information
Financials
GLAXOSMITHKLINE PLC
Company Overview
Product Information
Development and Strategies
Financials
KONINKLIJKE PHILIPS N.V. (RESPIRONICS, INC.)
Company Overview
Product Information
LUPIN, LIMITED
Company Overview
Development and Strategies
Financials
MYLAN N.V.
Company Overview
Product Information
Development and Strategies
Financials
NOVARTIS AG
Company Overview
Product Information
Development and Strategies
Financials
OMRON CORPORATION
Company Overview
Product Information
Development and Strategies
Financials
PFIZER, INC.
Company Overview
Product Information
Financials
PULMATRIX, INC.
Company Overview
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Company Overview
Product Information
Development and Strategies
Financials
VECTURA GROUP PLC
Company Overview
Product Information
Development and Strategies
Financials
Chapter 10 Appendix
Acronyms

詳細目次はデータリソースまでお申し付けください。

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る